Transcutaneous Electrical Stimulation for Spasticity in Patients With Primary Lateral Sclerosis

Key facts

Sponsor

Nova Southeastern University

Principal Investigator

Eduardo Locatelli, MD, MPH

Nova Southeastern University

Intervention

Transcutaneous electrical stimulation(device)

Enrollment

6 enrolled

Eligibility

18-90 years · All sexes

Timeline

2023 – 2024

Study locations (1)

• NSU Health Neuroscience Institute, Davie, Florida, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Primary lateral sclerosis

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE1NCT02868567
  Use of Dalfampridine in Primary Lateral Sclerosis
  Hospital for Special Surgery, New York
• RECRUITINGNCT02567136
  Imaging Biomarkers in ALS
  University of Minnesota

See all trials for Primary lateral sclerosis →